Examination of the Corpus Callosum from Magnetic Resonance Images of Patients with Parkinson’s Disease
PDF
Cite
Share
Request
Original Article
VOLUME: 13 ISSUE: 4
P: 361 - 366
December 2025

Examination of the Corpus Callosum from Magnetic Resonance Images of Patients with Parkinson’s Disease

Namik Kemal Med J 2025;13(4):361-366
1. Tekirdağ Namık Kemal University Vocational School of Health Services, Physiotherapy Program, Tekirdağ, Türkiye
2. Tekirdağ Namık Kemal University Faculty of Medicine, Department of Anatomy, Tekirdağ, Türkiye
3. Tekirdağ City Hospital, Clinic of Radiology, Tekirdağ, Türkiye
No information available.
No information available
Received Date: 09.07.2025
Accepted Date: 05.08.2025
Online Date: 19.12.2025
Publish Date: 19.12.2025
PDF
Cite
Share
Request

ABSTRACT

Aim

In recent years, studies investigating white matter involvement, which is considered the cause of sensory symptoms that appear earlier than motor symptoms in Parkinson’s disease, have increased. This study aims to investigate the involvement of the corpus callosum, the largest white matter structure connecting the two hemispheres, in Parkinson’s disease, taking into account age and sex differences.

Materials and Methods

Our study were retrospectively compared the measurements of corpus callosum length, width, and angle on midsagittal magnetic resonance images from 120 controls without any diagnosis affecting the corpus callosum and from 120 patients diagnosed with Parkinson’s disease.

Results

The height of the corpus callosum, the distance from the anterior tip to the top, and the distance from the anterointernal tip to the vertex increased, and the genu and rostrum width and the ratio of corpus callosum width to height decreased significantly in Parkinson’s disease patients (p<0.05). Based on the angular measurements, it was determined that the mean value of Angle 2 decreased in patients with Parkinson’s disease, while the values of Angle 4 and Angle 5 increased significantly (p<0.05).

Conclusion

It appears that there are few studies examining the involvement of the corpus callosum in Parkinson’s disease, and to the best of our knowledge, no studies have evaluated the known angle parameters. Therefore, it is believed that research in this area may provide a novel perspective for clinicians and surgeons.

Keywords:
Corpus callosum, magnetic resonance images, Parkinson’s disease, white matter

INTRODUCTION

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a decrease or complete loss of dopamine release1. While gray matter structures in the brain are emphasized in the pathogenesis of PD, recent studies have revealed their effects on white matter structures and increased the tendency to investigate this subject.

Many studies using various techniques have demonstrated that the corpus callosum, the largest white matter structure facilitating the transfer and integration of lateralized cognitive, motor, and sensory information between the cortices, is affected in PD2-5. Some studies indicate that these effects may manifest much earlier than changes in gray matter, underscoring their significance for early-stage diagnosis6, 7.

The aim of this study is to investigate the changes in width, length, and angle that occur in the corpus callosum, taking into account measurement parameters that have not been previously examined, through magnetic resonance images (MRI).

MATERIALS AND METHODS

Study Population

This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Non-Interventional Clinical Research Ethics Committee of Tekirdağ Namık Kemal University (decision no: 2021.74.03.14, date: 30.03.2021). In this study, images archived in the hospital’s picture archiving and communication system were retrospectively reviewed. Ethical approval was obtained, and the ethics committee stated that informed consent was not required due to the retrospective nature of the study. The data obtained from the PD group and the control group were analyzed by stratified sampling method, grouped by age and gender. A total of 500 MRI images from patients with PD were available as the study population. Based on the calculations, considering the small effect size, a 95% confidence interval, a 5% margin of error, and the sample sizes in other studies, the sample size was determined to be 120 MRI images from the PD group, obtained between 2018 and 2021 from patients without any other diagnosis affecting the corpus callosum, and 120 MRI images from the control group.

MRI images, including T1 and T2 sequences, were obtained in the cranial sagittal plane using a 1.5 Tesla MRI machine (Canon Vantage Elan or Philips Intera; Philips Medical Systems) and an eight-channel head coil. The images had a slice thickness of 5 mm and were analyzed using the programs OrDICOM 1.0 and Weasis 3.7.1.

The demographic data and group distributions of the participants are presented in Table 1.

Corpus Callosum Measurement Parameters

The corpus callosum is divided into four parts: rostrum, genu, truncus, and splenium. Measurements of length, height, width, and angle were taken for both groups using MRI images from the midsagittal section. Length, height, and width measurements are given in mm, while angle measurements are in degrees. All measurement sites are shown in Figure 1.

Statistical Analysis

The data were analyzed using IBM SPSS 24.0 software (Armonk, New York, USA), with a significance value of p<0.05. To compare changes across different age groups, the data were divided into six groups: 30-40 years (Group I), 41-50 years (Group II), 51-60 years (Group III), 61-70 years (Group IV), 71-80 years (Group V), and 81 years and above (Group VI).

RESULTS

Corpus Callosum Metric Measurement Results

The mean values of all morphometric measurements for both groups are presented in Table 2.

The averages of corpus callosum length (CCL), corpus callosum height (CCH), cerebrum length (CL), distance between the corpus callosum front end to vertex distance (FV), and distance between the corpus callosum anterointernal tip to vertex distance (AIV) were found to be greater in men than in women (p<0.05).

Analysis of the group of individuals diagnosed with PD by sex revealed statistically significant differences in CCL (p=0.007), CCH (p=0.008), rostrum width (RW) (p=0.012), and CL (p<0.001). The averages of the other parameters did not differ significantly by sex. As a result of the data analysis based on age groups, it was observed that the average values of corpus callosum width (CCW), genu width (GW), splenium width (SW), RW, and trunk width maximum (TWmax) decreased as the age of patients with Parkinson’s disease increased, while the average values of CCH, FV, and AIV increased.

in patients with PD, especially those aged 81 years and older, CCW, GW, SW, and TWmax showed a significantly greater decrease compared to controls (p<0.05). However, AIV was significantly higher in patients with PD, aged 81 years and older. In patients with PD, it has been observed that these significant changes begin to become noticeable between the ages of 51 and 60 and accelerate after the age of 81. The ratio of CCW to CCH was also significantly lower in the PD group (p=0.001).

Corpus Callosum Angle Measurement Results

All the measurement results are presented in Table 3.

After comparing the average angles across different age groups, significant differences were found in Angle 1, Angle 2, and Angle 4 between the PD group and the control group, particularly in the 30-40 age group. Further analysis within the PD group showed statistically significant differences in Angle 1, angle 2, and Angle 5 values across different age groups (p<0.05). Specifically, Angle 2 decreases with age in patients with PD, while Angle 5 increases with age.

According to the analysis of the data set, there were weak negative correlations between age and SW (r=-0.263) and between age and TWmin (r=-0.216), and moderate negative correlations between age and CCW (r=-0.352), GW (r=0.568), RW (r=-0.347), and TWmax (r=-0.394). Additionally, weak positive relationships were detected between age and CCH (r=0.289), FV (r=0.205), Angle 4 (r=0.280), and Angle 5 (r=0.266). In the PD group, there was a weak negative correlation between age and Angle 2 (r=-0.197), but a weak positive correlation between age and Angle 4 (r=0.207) and Angle 5 (r=0.250). It is important to note that these correlations were not observed in the control group.

In the PD group, certain length measurements showed different correlation results compared to those in the control group. Specifically, there was a weak negative correlation between GW and CCH (r=-0.269, p=0.003). Moreover, moderate positive correlations were observed between CCH and RW (r=0.416, p<0.001) as well as between CCH and CL (r=0.310, p=0.001). Additionally, a weak positive relationship was found between CL and TWmax (r=0.187, p=0.041).

DISCUSSION

In PD, Lewy bodies affect gray matter structures and damage white matter connections, leading to non-motor symptoms such as cognitive impairment and depression8. Investigating changes in white matter fiber tracts may provide a better understanding of the underlying mechanism of PD. Our study is one of the most comprehensive studies to measure a wide range of parameters of the corpus callosum in MRI images of patients diagnosed with PD, including parameters that have not been previously evaluated.

Our research shows that women have smaller CCL and CL values than men, consistent with the findings of Mohammadi et al.9 (p<0.005). When comparing patients with PD with healthy individuals, we found that genu and SW decreased in the PD group, while CCL and CL increased; however, these changes were not statistically significant except for GW. Mohammadi et al.9 also found a positive relationship between CCL, CL, and CCW. Our findings support this result. We found a moderate positive correlation between CCL and CL in both the control group and the PD group.

Studies comparing patients with PD with healthy control groups have found that the corpus callosum thickness, particularly in the anterior half, is reduced in Parkinson’s patients10, 11. Significant decreases in volume in the anterior 2/5 of the corpus callosum and fractional anisotropy have also been observed in Parkinson’s patients2. This is associated with impaired information processing in the prefrontal cortex, motor, and supplementary motor areas12. Gattellaro et al.13, in their functional MRI study, suggested that the microstructure of the corpus callosum genu in patients with PD was impaired even at an early stage, while Guimarães et al.3 suggested that changes in the corpus callosum, which they examined with diffusion tensor imaging, began to be observed at later stages. Furthermore, a clear connection between vascular parkinsonism and issues in the genu of the corpus callosum has been identified14. Reduced fiber density in the genu and body is related to gait asymmetry2, 15. Our findings indicate that genu and RW are reduced in the PD group (p<0.001) and that the genu section is more affected in older patients with PD. The genu section of the corpus callosum is associated with cognitive functions, attention, and executive disorders; therefore, genu involvement may affect symptoms such as dementia, distractibility, and impaired control of planned movements10, 16.

In the study by Bledsoe et al.17, the corpus callosum in patients with PD was divided into five regions and examined using the diffusion tensor imaging method. The study showed an increase in axial diffusivity and a decrease in fractional anisotropy in the anterior 3/5 of the corpus callosum. These findings indicate damage to myelinated fibers and white matter atrophy. Our study results are also consistent with these findings. This supports the observation of a reduction in the number of fibers and microstructural atrophy in the affected regions identified through metric measurements.

In a study in which the distance from the vertex of the corpus callosum to the anterior commissure was evaluated as the CCH, it was reported that the CCH increased with age18. As in our study, in another study where the CCH was determined by measuring the distance between the tangent lines to the highest and lowest points of the corpus callosum, it was found that the height increased with age19. Our study revealed that height increased with age in both the control group and the group diagnosed with PD, with the group diagnosed with PD having a significantly greater mean CCH (p<0.001). This increase in height also resulted in a significant difference between the two groups in the average values of the FV and AIV parameters (p<0.05). Additionally, in patients with PD as CCH increased, RW and CL also increased, while GW decreased.

In some studies, the values measured as Angle 1 and Angle 2 have been expressed as the corpus callosum bending angle. In studies involving patients with schizophrenia spectrum disorders and niemann-pick type C, no significant differences were observed in Angle 1 with respect to age, sex, or between groups20, 21. Similarly, in a study comparing patients with Williams syndrome to healthy individuals, no significant difference was found in terms of Angle 222. In our study, while there was no difference in Angle 1 between sexes or groups (p>0.05), the value of Angle 2 was significantly lower in the PD group (p=0.027). Both angles were observed to be higher in the 41-50 age group of patients with PD and decreased with advancing age. This study found that the decrease in Angle 2 was more significant in the Parkinson’s group compared to the control group, especially after the age of 41-50. This finding may indicate a potential increase in the bending of the corpus callosum due to the progression of PD.

Angle 5 indicates the position of the anterior part of the corpus callosum relative to the floor of the 4th ventricle23. In one study, frontal dysplasia was found to increase Angle 5, and no difference was observed between autistic and non-autistic individuals with macrocephaly24. In our study, the increase in the average value of Angle 5 in the PD group was found to be statistically significant (p<0.001), which may indicate an increased tendency for frontal localization of the corpus callosum in PD patients.

Study Limitations

This study has some limitations. First, the retrospective design limits the ability to control for potential confounding variables. Second, the evaluation was based solely on midsagittal MRI images, which may not fully reflect all microstructural changes in the corpus callosum. We believe that including clinical data such as disease duration, medication use, or cognitive status in future studies would allow for a more comprehensive analysis, and this study serves as a guiding basis for such research.

CONCLUSION

In conclusion, PD is a progressive neurodegenerative condition that affects daily activities and reduces quality of life, making early diagnosis crucial for successful treatment. Therefore, there is a necessity to conduct research on white matter, as developing new perspectives and focusing on new methods in this area is essential. The consistency of results across studies using different methodologies enhances the reliability of these findings. We believe our study is significant for supporting findings from other techniques, being one of the most comprehensive studies focusing specifically on the corpus callosum, and adding new measurement parameters to the literature.

Ethics

Ethics Committee Approval: This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Non-Interventional Clinical Research Ethics Committee of Tekirdağ Namık Kemal University (decision no: 2021.74.03.14, date: 30.03.2021).
Informed Consent: The study is a retrospective study.

Authorship Contributions

Concept: D.T., A.Z., Design: D.T., A.Z., Data Collection or Processing: D.T., A.Z., S.A., Analysis or Interpretation: D.T., A.Z., S.A., Literature Search: D.T., A.Z., S.A., Writing: D.T., A.Z.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Thomas B, Beal MF. Parkinson’s disease. Hum Mol Genet. 2007;16 Spec No. 2:R183-94.
2
Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease. Neurology. 2017;88:1265-72.
3
Guimarães RP, Campos BM, de Rezende TJ, Piovesana L, Azevedo PC, Amato-Filho AC, et al. Is diffusion tensor imaging a good biomarker for early Parkinson’s disease? Front Neurol. 2018;9:626.
4
Lenka A, Pasha SA, Mangalore S, George L, Jhunjhunwala KR, Bagepally BS, et al. Role of corpus callosum volumetry in differentiating the subtypes of progressive supranuclear palsy and early Parkinson’s disease. Mov Disord Clin Pract. 2017;4:552-8.
5
Yang K, Wu Z, Long J, Li W, Wang X, Hu N, et al. White matter changes in Parkinson’s disease. NPJ Parkinsons Dis. 2023;9:150.
6
Lee SH, Kim SS, Tae WS, Lee SY, Choi JW, Koh SB, et al. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR Am J Neuroradiol. 2011;32:682-7.
7
Rektor I, Svátková A, Vojtíšek L, Zikmundová I, Vaníček J, Király A, et al. White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy. PLoS One. 2018;13:e0187939.
8
Li Y, Huang P, Guo T, Guan X, Gao T, Sheng W, et al. Brain structural correlates of depressive symptoms in Parkinson’s disease patients at different disease stage. Psychiatry Res Neuroimaging. 2020;296:111029.
9
Mohammadi MR, Zhand P, Mortazavi Moghadam B, Golalipour MJ. Measurement of the corpus callosum using magnetic resonance imaging in the north of İran. Iran J Radiol. 2011;8:218-23.
10
Bledsoe I. Abnormal corpus callosum morphometry in parkinson’s disease: Rush University. Available from: https://www.proquest.com/-docview/1791463709?pqorigsite=gscholar&fromopenview=true&sourcetype=Dissertations%20&%20Theses
11
Deng B, Zhang Y, Wang L, Peng K, Han L, Nie K, et al. Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson’s disease. Am J Alzheimers Dis Other Demen. 2013;28:154-64.
12
Wei X, Luo C, Li Q, Hu N, Xiao Y, Liu N, et al. White matter abnormalities in patients with Parkinson’s disease: a meta-analysis of diffusion tensor imaging using tract-based spatial statistics. Front Aging Neurosci. 2021;12:610962.
13
Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, et al. White matter involvement in idiopathic parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2009;30:1222-6.
14
Wang HC, Hsu JL, Leemans A. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity. Arch Neurol. 2012;69:1340-8.
15
Fling BW, Curtze C, Horak FB. Gait asymmetry in people with Parkinson’s disease is linked to reduced integrity of callosal sensorimotor regions. Front Neurol. 2018;9:215.
16
Atkinson-Clement C, Pinto S, Eusebio A, Coulon O. Diffusion tensor imaging in Parkinson’s disease: review and meta-analysis. Neuroimage Clin. 2017;16:98-110.
17
Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG. White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease. Neurology. 2018;91:e2244-55.
18
Al Hadidi MT, Kalbouneh HM, Ramzy A, Sharei AA, Badran DH, Shatarat A, et al. Gender and age-related differences in the morphometry of corpus callosum: MRI study. Eur J Anat. 2021;25:15-24.
19
Takeda S, Hirashima Y, Ikeda H, Yamamoto H, Sugino M, Endo S. Determination of indices of the corpus callosum associated with normal aging in Japanese individuals. Neuroradiology. 2003;45:513-8.
20
Walterfang M, Wood AG, Barton S, Velakoulis D, Chen J, Reutens DC, et al. Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1050-7.
21
Walterfang M, Fahey M, Abel L, Fietz M, Wood A, Bowman E, et al. Size and shape of the corpus callosum in adult niemann-pick type c reflects state and trait illness variables. AJNR Am J Neuroradiol. 2011;32:1340-6.
22
Sampaio A, Bouix S, Sousa N, Vasconcelos C, Férnandez M, Shenton ME, et al. Morphometry of corpus callosum in Williams syndrome: shape as an index of neural development. Brain Struct Funct. 2013;218:711-20.
23
Giffoni SD, Gonçalves VM, Zanardi VA, Lopes VL. Angular analysis of corpus callosum in 18 patients with frontonasal dysplasia. Arq Neuropsiquiatr. 2004;62:195-8.
24
Rice SA, Bigler ED, Cleavinger HB, Tate DF, Sayer J, McMahon W, et al. Macrocephaly, corpus callosum morphology, and autism. J Child Neurol. 2005;20:34-41.